NASH Accelerated Approval: US FDA Remains Confident In Pathway For Liver Disease
• By Michael McCaughan
NASH (non-alcoholic steatohepatitis) is now also known as MASH (metabolic dysfunction associated steatohepatitis). • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
